Kingworld Medicines Group Limited
Kingworld Medicines Group Limited (HKSE: 1110) is trading at HK$0.37, about ₹5 at today's HKD/INR rate, as of 25 Sep 2026, 4:08 AM ET, down 3.90% today. Indian residents can buy Kingworld Medicines from India on Paasa under the RBI's Liberalised Remittance Scheme.
Quote
Today's low
HK$0.37
Today's high
HK$0.39
52 week low
HK$0.33
52 week high
HK$0.78
1110 opened at HK$0.39, closed previously at HK$0.39, and has traded between HK$0.33 and HK$0.78 over the past 52 weeks.
About
Kingworld Medicines Group Limited functions as an investment holding company primarily engaged in the distribution of imported, branded pharmaceutical and healthcare items. The company also supplies a range of medical products, health goods, and general food items. Its extensive product catalog caters to various therapeutic areas, such as respiratory relief (for cough and phlegm), gastrointestinal issues, vitamin supplementation, orthopedic support, cardiovascular health, and influenza care. Key brands distributed include Nin Jiom Chuan Bei Pei Pa Koa, Taiko Seirogan, the Kawai Product Range, Flying Eagle Wood Lok Medicated Oil, Kyushin Pill, and the Mentholatum Product Range. Furthermore, Kingworld is involved in the production and sale of electrotherapeutic and physiotherapeutic devices, as well as common medical examination equipment. Its market presence spans the People's Republic of China, Hong Kong, the United States, the United Kingdom, Germany, Italy, Spain, Mexico, and other international regions. The company, founded in 1996, is headquartered in Shenzhen, PRC.
Key statistics
Avg. volume
2.14M
Market cap
HK$218.23M
P/E Ratio
16.73
Price-to-sales ratio
0.24
Enterprise value
CN¥445.98M
Free cash flow yield
26.30%
Debt-to-equity ratio
0.73
Return on equity
1.89%
ROIC
3.56%
Beta
0.85
Dividend yield
0.00%
Last dividend
HK$0.00
Financial overview
Revenue
CN¥917.34M
Earnings per share
CN¥0.02
Free cash flow
CN¥54.92M
Net profit margin
1.46%
Gross margin
30.47%
EBITDA
CN¥72.03M
Revenue growth
-13.55%
Similar securities
This is not an investment recommendation
How to buy Kingworld Medicines from India
Indian residents can buy Kingworld Medicines shares through Paasa in four steps. Funds leave India under the RBI's Liberalised Remittance Scheme and the shares are held in your own name with Interactive Brokers.
Open a Paasa account
Complete digital KYC with your PAN, Aadhaar and address proof. Your brokerage account is opened in your own name with Interactive Brokers.
Add funds under LRS
Transfer INR from your Indian bank account. Your bank reports the remittance under the RBI's Liberalised Remittance Scheme and converts it to US dollars and then to HKD.
Search for Kingworld Medicines and place an order
Find Kingworld Medicines by name or by its ticker, 1110, and choose an order type. Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share. Kingworld Medicines trades 7:00 am – 1:30 pm IST; orders can only execute during that window.
Track holdings and download tax reports
Follow your Kingworld Medicines position in HKD and INR. Kingworld Medicines pays no dividend today, so your filing is the capital-gains statement plus the Schedule FA holding line.
Read the full guide: how to invest in Kingworld Medicines from India
Trading and taxes when buying Kingworld Medicines from India
Trading and limits
- Trading hours
- 9:30 am – 4:00 pm HKT
- LRS limit
- $250,000Per financial year, under the RBI's Liberalised Remittance Scheme.
Tax for Indian residents
- TCS on remittance
- 20%Collected by your bank on LRS remittances above ₹10 lakh in a financial year. The TCS is adjustable against your income-tax liability.Adjusting TCS against your tax
- Capital gains in India
- 12.5% or slab rateGains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate.Capital gains explained
- Dividends
- NoneKingworld Medicines does not currently pay a dividend. If it starts, dividends are taxed at your slab rate in India.Dividend tax explained
Custody. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
FAQs
Can Indian residents buy Kingworld Medicines stock?
Yes. Kingworld Medicines (1110) has been listed on the Hong Kong Stock Exchange since 2010, in the Medical - Distribution industry, and Indian residents can buy it through Paasa. You fund the account from your Indian bank under the RBI's Liberalised Remittance Scheme and the money is converted to US dollars and then to HKD. Shares are held in your own name at Interactive Brokers, segregated from Paasa's own assets.
How much does one Kingworld Medicines share cost in rupees?
One Kingworld Medicines share is HK$0.37 — about ₹5 at an HKD/INR rate of 12.23 on 25 Sep 2026. Both the Kingworld Medicines price and the rupee rate move during the day, so the rupee cost changes with them.
What are the LRS and TCS rules for buying Kingworld Medicines from India?
Remit up to $250,000 per financial year under the RBI's Liberalised Remittance Scheme (LRS). Banks collect 20% tax at source on LRS remittances above ₹10 lakh in a financial year; the TCS is adjustable against your income-tax liability. FX and the LRS declaration are handled by your bank when you fund your account.
What is the minimum I can buy of Kingworld Medicines?
Many Hong Kong listings trade in board lots, so the smallest order is one lot rather than one share.
How are gains on Kingworld Medicines shares taxed in India?
Hong Kong generally does not levy capital gains tax on non-resident individual investors for HKEX-listed stocks, so the tax is an India-side one. Gains on shares held for more than 24 months are long-term and taxed at 12.5%. Gains on shares held for 24 months or less are short-term and taxed at your income-tax slab rate. The gain is computed in rupees using the HKD/INR rate on the purchase and the sale date, so the rupee move counts alongside the Kingworld Medicines price. Paasa issues a capital-gains statement for your return.
Does Kingworld Medicines pay a dividend?
No. Kingworld Medicines does not currently pay a dividend, so holding it produces no dividend income to declare in India. If it starts paying one, the Indian treatment is the usual one — dividends are taxed at your slab rate in India — and Paasa's dividend report would show the gross amount and any tax withheld.
When can I trade Kingworld Medicines from India?
The Hong Kong Stock Exchange trades 7:00 am – 1:30 pm IST in Indian time. It also halts for lunch, 9:30 am – 10:30 am IST. Orders can only execute during that window.
Is Kingworld Medicines a Hong Kong SAR China company, and does that change how it is taxed?
Kingworld Medicines trades on the Hong Kong Stock Exchange in HKD, but the company is domiciled in China. Kingworld Medicines trades as an ordinary share listed directly in Hong Kong, not a depositary receipt. Your India-side capital-gains treatment is the same either way.
Do I have to declare Kingworld Medicines shares in my Indian tax return?
Yes. Foreign shares held on 31 March must be reported in Schedule FA of your Indian income-tax return. Paasa gives you a Schedule FA-ready statement listing your Kingworld Medicines holding, its cost and its closing value.
How do I sell Kingworld Medicines and bring the money back to India?
You sell during market hours (7:00 am – 1:30 pm IST) and the proceeds settle in HKD in your Paasa account. From there you can hold the balance, reinvest, or repatriate. Funds can be withdrawn in any currency to any bank account in your own name. Whether the sale is short- or long-term is decided by the 24-month holding period.